Skip to main content
. 2007 Jul 24;97(4):458–463. doi: 10.1038/sj.bjc.6603902

Table 4. Evaluation of toxicity per patient.

  Number of patients (N=52)
   
  G1 G2 G3 G4 Toxicity of all gradesa (%) Toxicity of grade 3–4 (%)
Haematologic toxicity
 Anaemia 8 23 2 1 65 6
 Leukopaenia 6 9 3 35 6
 Neutropaenia 7 7 5 37 10
 Thrombocytopaenia 4 2 2 15 4
             
Non-haematologic toxicity
 Diarrhoea 10 3 7 39 14
 Nausea 17 10 1 54 2
 Vomiting 8 7 1 32 2
 Mucositis 15 4 37
 Anorexia 15 20 7 81 14
 Fatigue 17 13 5 67 10
 Weight loss 4 3 14
 Dyspepsia 15 5 1 40 2
 Skin rash 8 1 17
 Itching sensation 12 2 27
 Skin pigmentation 13 1 27
 Hand – foot syndrome 2 2 1 10 2
 Abdominal pain 12 2 27
 Elevated creatinine 8 15
 Elevated AST/ALT 10 4 27
 Elevated ALP 12 1 2 1 29 6
 Hyperbilirubinaemia 8 2 1 1 23 4

ALP=alkaline phosphatase; ALT=alanine aminotransferase; AST=aspartate aminotransferase; G=Grade.

a

Grading was according to the NCI-Common Toxicity Criteria (Version 2.0).